LOUISVILLE, Ky.–(BUSINESS WIRE)– Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by GlaxoSmithKline for OJJAARA™ (momelotinib). OJJAARA is a kinase inhibitor indicated for the treatment of intermediate or high-risk myelofibrosis (MF), including primary MF or secondary MF [post-polycythemia vera (PV) and post-essential thrombocythemia (ET)], in adults with anemia. “Onco360 […]
Monthly Archives: September 2023
25
Sep
Sep
Newswise — Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at Linköping University, Sweden. […]
The use of molnupiravir to treat at-risk COVID patients coincides with mutations of the virus, scientists say. An antiviral drug used to treat COVID-19 infections has been linked to coronavirus mutations that are suspected of then being passed on to other people, researchers say. ADVERTISEMENT Scientists mapped COVID-19 mutations over time to see how and […]
Cardiovascular
Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis
25
Sep
Sep
Abstract Phosphate binders are the main treatment for hyperphosphatemia in patients with chronic kidney disease, and iron-based phosphate binders have been used with increasing frequency in recent years. This study examined the association of the use of iron-based, rather than non-iron-based, phosphate binders with the incidence of cardiovascular events, in a real-world setting. We used […]
25
Sep
Sep
Haug CJ, Drazen JM. Artificial intelligence and machine learning in clinical medicine, 2023. N Engl J Med. 2023;388(13):1201–8. Article CAS PubMed Google Scholar Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56. Article CAS PubMed Google Scholar Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, et […]
Cancer and neoplasms
Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies – Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek
25
Sep
Sep
New York, USA, Sept. 25, 2023 (GLOBE NEWSWIRE) — Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies – Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek The dynamics of the chronic obstructive pulmonary disease market are anticipated to change in the coming years owing […]
25
Sep
Sep
September 25, 2023 2 min read Source/Disclosures Source: Brustad N, et al. Abstract PA2721. Presented at: European Respiratory Society International Congress; Sept. 9-13, 2023; Milan. Disclosures: Brustad reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email […]
25
Sep
Sep
Pregnancy is a risk factor for severe COVID-19 A 2021–2022 observational study found that a COVID-19 diagnosis during pregnancy increased risk of morbidity and death for the pregnant patient (relative risk [RR] 1.16, 95% confidence interval [CI] 1.03–1.31), and that SARS-CoV-2 vaccination was protective from severe disease and death. Unvaccinated pregnant patients were found to […]
Cancer and neoplasms
Laterality influence on gene expression of DNA damage repair in colorectal cancer
25
Sep
Sep
Abstract Colorectal carcinoma (CRC) is the third most common malignancy worldwide, and second in number of deaths in the world. The molecular pathogenesis of CRC is heterogeneous and can affect several genes. Moreover, genomic instability is recognized as an important part of CRC carcinogenesis and is tightly connected to DNA damage response. DNA damage repair […]
Cancer and neoplasms
Clinical and microbiological characterization of Salmonella spp. isolates from patients treated in a university hospital in South America between 2012–2021: a cohort study
25
Sep
Sep
An absence of information about the patterns of Salmonellosis in Latin America has been identified and an imperative need has arisen to generate population and clinical studies to evaluate disease dynamics, mortality and risk factors for severe disease [11, 19]. This study contributes to the generation of knowledge about clinical patterns, resistance, mortality and related […]